Akari Therapeutics PLC (AKTX)
1.36
-0.11
(-7.48%)
USD |
NASDAQ |
May 03, 16:00
1.39
+0.03
(+2.21%)
After-Hours: 20:00
Akari Therapeutics Total Return Price: 1.36 for May 3, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.36 |
| May 02, 2024 | 1.47 |
| May 01, 2024 | 1.70 |
| April 30, 2024 | 1.54 |
| April 29, 2024 | 1.280 |
| April 26, 2024 | 1.185 |
| April 25, 2024 | 1.19 |
| April 24, 2024 | 1.19 |
| April 23, 2024 | 1.21 |
| April 22, 2024 | 1.18 |
| April 19, 2024 | 1.166 |
| April 18, 2024 | 1.21 |
| April 17, 2024 | 1.121 |
| April 16, 2024 | 1.156 |
| April 15, 2024 | 1.20 |
| April 12, 2024 | 1.21 |
| April 11, 2024 | 1.10 |
| April 10, 2024 | 1.30 |
| April 09, 2024 | 1.315 |
| April 08, 2024 | 1.40 |
| April 05, 2024 | 1.41 |
| April 04, 2024 | 1.44 |
| April 03, 2024 | 1.55 |
| April 02, 2024 | 1.51 |
| April 01, 2024 | 1.51 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.865 |
| March 27, 2024 | 1.86 |
| March 26, 2024 | 1.885 |
| March 25, 2024 | 1.900 |
| March 22, 2024 | 1.81 |
| March 21, 2024 | 1.83 |
| March 20, 2024 | 1.900 |
| March 19, 2024 | 1.94 |
| March 18, 2024 | 2.000 |
| March 15, 2024 | 1.97 |
| March 14, 2024 | 2.04 |
| March 13, 2024 | 2.15 |
| March 12, 2024 | 2.14 |
| March 11, 2024 | 2.150 |
| March 08, 2024 | 2.14 |
| March 07, 2024 | 2.22 |
| March 06, 2024 | 2.20 |
| March 05, 2024 | 2.260 |
| March 04, 2024 | 2.25 |
| March 01, 2024 | 2.28 |
| February 29, 2024 | 2.35 |
| February 28, 2024 | 2.22 |
| February 27, 2024 | 2.29 |
| February 26, 2024 | 2.372 |
| February 23, 2024 | 2.340 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
1.10
Minimum
Apr 11 2024
77.60
Maximum
Feb 19 2021
25.71
Average
31.00
Median
Apr 13 2020
Total Return Price Benchmarks
| DBV Technologies SA | 0.6669 |
| Cellectis SA | 2.99 |
| Adaptimmune Therapeutics PLC | 1.19 |
| Biodexa Pharmaceuticals Plc | 1.18 |
| NuCana PLC | 4.00 |